SCHEMBL6022609

SCHEMBL6022609

CCCCOc1cc(/C=C/C(=O)N2CCN(c3ccc(NC(=N)c4cccs4)cc3)CC2)cc(OCCCC)c1O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.47
POLB P06746 2/20 0.47
HTT P42858 2/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
THRB P10828 1/20 0.46
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 2/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
MCL1 Q07820 1/20 0.43
ACHE P22303 3/20 0.43
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022613 1.00 MAPT (0.47) MAPTPOLBHTTKMT2AMEN1
Hydrochloric Acid SCHEMBL6022939 0.99 MAPT (0.46) MAPTPOLBHTTKMT2AMEN1
Hydrochloric Acid SCHEMBL6022936 0.99 MAPT (0.46) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6023441 0.98 KMT2A (0.49) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6023444 0.98 KMT2A (0.49) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6022674 0.97 KMT2A (0.51) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6022599 0.97 KMT2A (0.51) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6022601 0.97 KMT2A (0.51) MAPTPOLBHTTKMT2AMEN1
SCHEMBL6022676 0.97 KMT2A (0.51) MAPTPOLBHTTKMT2AMEN1
SCHEMBL7031592 0.97 KMT2A (0.51) MAPTPOLBHTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US claimed
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 MAPT 69/4885POLB 2157/4885HTT 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.